Specialty Networks Partners With Datavant to Add Real-World Data

April 25, 2022
Provider of specialty care performance and population health analytics adds data sources such as claims, labs, imaging, mortality events, and social determinants of health to its registry

Specialty Networks, a provider of urology, gastroenterology, and rheumatology care performance and population health analytics, is partnering with Datavant to offer its customers real-world data to support their clinical networks and life sciences research.

Specialty Networks serves more than 7,000 community urology providers which represents 80 percent of all independent U.S. urology physicians as well as a growing network of gastroenterology and rheumatology physician practices. Its solutions include population health management, patient engagement, clinical research, and workflow automation technologies.  

Datavant says it offers the ability to access, exchange, and connect data among the thousands of organizations in its ecosystem for use cases ranging from better clinical care and value-based payments to health analytics and medical research.

Leveraging Datavant’s ecosystem of more than 500 real-world data partners, Specialty Networks said it would link other data sources such as claims, labs, imaging, mortality events, and social determinants of health to create a complete longitudinal patient journey. Stakeholders will be able to use this de-identified data to conduct a spectrum of outcomes research across clinical development, health economics, outcomes research, medical affairs, and commercial functions to understand the patient populations and medical conditions diagnosed and treated in the community physician practice setting.

“Entering into a like-minded partnership with Datavant to create an enriched patient journey enables us to help our provider networks improve care and simultaneously create a privacy-compliant data asset that can advance research into diseases like prostate, bladder, and kidney cancers, Peyronie’s disease, overactive bladder, benign prostatic hyperplasia, inflammatory bowel disease, rheumatoid, psoriatic, and osteoarthritis, and other urological, gastroenterological, and rheumatological diseases,” said Shailendra Sharma, president of Specialty Networks, in a statement. “SoNaR — Specialty Networks Registry — represents the family of highly curated specialty registries in urology, gastroenterology, and rheumatology for various tumors and disease states.”

“Every therapeutic area is witnessing an explosion of best-in-class data and analytics companies emerging that help to make research and treatment more data-driven, creating the hope for major benefits for patients,” added Travis May, founder and president of Datavant, in a statement. “Specialty Networks is establishing a gold standard in urology for real-world evidence research with its SoNaR registry and technology stack that integrates a large proportion of independent community physician practices across the country. We're excited to work with them to connect their data to the rest of the health data ecosystem and help form a deeper understanding of diseases, diagnostics, and interventions.”

Sponsored Recommendations

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...